These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24101713)

  • 1. Nicotinic acid: current status in lipid management and cardiovascular disease prevention.
    Whayne TF
    Angiology; 2014 Aug; 65(7):557-9. PubMed ID: 24101713
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: is this a new immediate-release therapeutic option for niacin?
    Ledwidge MT; Ryan F; Kerins DM; O'Connell D; Cefali G; Harmon S; Jones M; Gilmer JF
    Atherosclerosis; 2012 Apr; 221(2):478-83. PubMed ID: 22326030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a nicotinic acid receptor: is this the molecular target for the oldest lipid-lowering drug?
    Pike NB; Wise A
    Curr Opin Investig Drugs; 2004 Mar; 5(3):271-5. PubMed ID: 15083592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niacin: vitamin and antidyslipidemic drug.
    Jacobson EL; Kim H; Kim M; Jacobson MK
    Subcell Biochem; 2012; 56():37-47. PubMed ID: 22116693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.
    Offermanns S
    Trends Pharmacol Sci; 2006 Jul; 27(7):384-90. PubMed ID: 16766048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid management in clinical practice.
    Jialal I; Devaraj S
    Curr Opin Lipidol; 2009 Aug; 20(4):350-2. PubMed ID: 19584593
    [No Abstract]   [Full Text] [Related]  

  • 8. Nicotinic acid: pharmacological effects and mechanisms of action.
    Gille A; Bodor ET; Ahmed K; Offermanns S
    Annu Rev Pharmacol Toxicol; 2008; 48():79-106. PubMed ID: 17705685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niacin: an old lipid drug in a new NAD
    Romani M; Hofer DC; Katsyuba E; Auwerx J
    J Lipid Res; 2019 Apr; 60(4):741-746. PubMed ID: 30782960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The facts behind niacin.
    Hochholzer W; Berg DD; Giugliano RP
    Ther Adv Cardiovasc Dis; 2011 Oct; 5(5):227-40. PubMed ID: 21893559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current world literature. Lipid metabolism.
    Curr Opin Lipidol; 2013 Jun; 24(3):265-73. PubMed ID: 23652471
    [No Abstract]   [Full Text] [Related]  

  • 12. Triglyceride modulation by acifran analogs: activity towards the niacin high and low affinity G protein-coupled receptors HM74A and HM74.
    Mahboubi K; Witman-Jones T; Adamus JE; Letsinger JT; Whitehouse D; Moorman AR; Sawicki D; Bergenhem N; Ross SA
    Biochem Biophys Res Commun; 2006 Feb; 340(2):482-90. PubMed ID: 16389067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From the Editor: New guidelines are coming.
    Brown WV
    J Clin Lipidol; 2017; 11(1):1-2. PubMed ID: 28391874
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nicotinic acid in lipid metabolism disorders].
    Ahmed K; Offermanns S
    Pharm Unserer Zeit; 2007; 36(2):120-5. PubMed ID: 17424997
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypolipidemic effect of a prodrug containing nicotinic acid in rats. Correlation with plasmatic levels.
    Filip C; Ungureanu D; Gheorghiţă N; Ghitler N; Mocanu G; Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(1):179-83. PubMed ID: 14755991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials.
    Lukasova M; Hanson J; Tunaru S; Offermanns S
    Trends Pharmacol Sci; 2011 Dec; 32(12):700-7. PubMed ID: 21944259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist.
    Tang H; Lu JY; Zheng X; Yang Y; Reagan JD
    Biochem Biophys Res Commun; 2008 Oct; 375(4):562-5. PubMed ID: 18722346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of niacin on atherosclerosis and vascular function.
    Ruparelia N; Digby JE; Choudhury RP
    Curr Opin Cardiol; 2011 Jan; 26(1):66-70. PubMed ID: 21045681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination lipid therapy in type 2 diabetes mellitus.
    Vergès B
    Expert Opin Pharmacother; 2011 Jun; 12(9):1393-403. PubMed ID: 21323502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niacin-a critical component to the management of atherosclerosis: contemporary management of dyslipidemia to prevent, reduce, or reverse atherosclerotic cardiovascular disease.
    Mason CM; Doneen AL
    J Cardiovasc Nurs; 2012; 27(4):303-16. PubMed ID: 21804401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.